Panelists discuss how advanced practice providers (APPs) play a central role in identifying and managing amyloid-related ...

While the cost of health care remains the dominant worry among Americans, the process of obtaining prior authorization from ...

Hair regrowth efficacy is the primary concern for AA patients, with insurance coverage and flare-up prevention also important ...

Aquestive Therapeutics announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Anaphylm (dibutepinephrine) Sublingual Film, a noninvasive ...

Glaucoma often remains asymptomatic until vision damage occurs, with angle-closure glaucoma requiring urgent medical attention due to acute symptoms. Risk factors include family history, age, ...

To make it happen, plans should start by offering true outreach flexibility, including live calls, mail, SMS, and digital options. They must let response data drive the next step (eg, text after a ...

Panelists discuss how shared decision-making is vital for empowering patients and caregivers. Advance practice providers (APPs) act as educators who translate complex medical information into ...

Patients with at least 1 chronic condition were more likely to be insured through commercial insurance, which can affect health care spending overall.

In this Q&A, Avitzur breaks down the study’s findings and suggests how the information can be used to advance PF research and treatments. This transcript has been lightly edited for clarity. AJMC: ...

Among patients with MCL still on study in January 2025, 35.3% reported improved MCL-related symptoms, while 5.9% reported ...

Manjool Shah, MD, clinical associate professor of ophthalmology and visual sciences for the Kellogg Eye Center, discussed how ...

The HELIOS-B trial previously showed that vutrisiran (Amvuttra; Alnylam Pharmaceuticals), a gene-silencing therapy that ...